Connect with us

Media & Technology

Major Move on MDM Permian, LLC (OTC: MDMP) as Co Reports Vast Oil Reserves at Permian Basin

Published

on

MDM Permian, LLC (OTC: MDMP) is in full beast mode rocketing up the charts in recent days after the Company reported it has over 20 million barrels of oil in the ground. MDMP is under heavy accumulation and has quickly emerged as the top most traded stock in small caps attracting legions of new shareholders. On Thursday alone MDMP traded over $100 million in dollar volume and rocketed up the charts over 200% as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no fundamentals compared to MDMP. 

According to the March 10 release:  “The study indicates that on the Lindley A lease, the Clearfork contains 3,578,310 barrels of recoverable oil per 640 acres. The San Angelo contains 5,158,000 barrels of recoverable oil per 640 acres. The reservoirs calculate to $567,860,150. @ $65. oil for the 2 zones combined. Our 1680-acre Lindley Ranch is estimated to contain 13,565,540 barrels of recoverable oil equivalent or expressed as dollar value, $881,760,100. These represent the Clearfork and San Angelo and have not considered other proven zones. The Canyon Sands have not yet been calculated and will significantly add to the total as our engineer estimates that the wells only achieved a 4% recovery. As a public company, inground reserves can be added to the books as an asset. These reserves will significantly increase the value of the company when added according to MDMP management. 

MDM Permian, LLC operating out of Carrolton, Texas is a publicly traded energy company with interests in oil and natural gas wells, mineral prospects. The Company’s business plan includes building value through reserves and production in the Permian Basin of Texas. The Company was registered in Texas in 2017 by Mr. Michael L. Rafael.  

MDM Energy, Inc. is a wholly owned subsidiary operating company of MDM Permian. MDM Energy, Inc. was incorporated in the state of Texas in 1981. The company has drilled over 125 oil & gas projects in the Illinois Basin over the last decade and had been involved in all aspects of oil and gas development in the basin for over 35 years. As founder and President, Michael L. Rafael has led the company since inception and takes an active, hands on approach to the business. Mr. Rafael has been directly involved with the drilling and or completion of over 350 oil and gas projects in Illinois, Kentucky and Texas. 

The Company is led by founder and CEO Michael L. Rafael who has 40 years of experience in the oil and gas industry, serving as founder, President and Chief Executive Officer of MDM Permian, Inc. Mr. Rafael is also founder and President of MDM Energy, Inc. Mr. Rafael has been directly involved in the drilling, completion, and operation of over 350 oil and gas wells, primarily in the Illinois Basin and the Ft. Worth Basin, and directly supervises and oversees all field operations. Mr. Rafael works directly with contract geologists, petroleum engineers, and geophysicists throughout all phases of operations. These include the generation of prospects, the acquisition of leases, and the gathering of scientific data as well as the planning and drilling of the prospects through completion and production. MDM Energy, Inc. provides pumping and maintenance services as well as water hauling and lease management in The Illinois Basin. 

Investor sentiment on MDMP is very high:

To Find out the inside Scoop on MDMP Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

MDMP

The stock has seen a parabolic rise after the Company announced the results of the refurbishment of the Lindley A lease wells, Irion County. On March 2 Permian Services, LLC, Midland Texas, moved a rig onto the Lindley 1-A well. On Wednesday we ran a packer to isolate and pressure test for holes in the casing at shallow depths. A hole was located at a depth of 2198 ft. We ordered Powerflex Cementing, LLC, Winters, Texas to apply a 150-sack squeeze job to patch the hole and stop the water infiltration. The attempt was successful, and we contracted a reverse unit from Basic Services to drill out the cement job. After that was done, a Mechanical Integrity Test was run on the well by Tri-Best, Inc. We then moved Tri-Best to the Lindley 2-A well to do a MIT. The charts from both tests are being submitted to the RRC. The planning of the next phase of our work is the completion of the Clearfork at 3800 ft. on the 1-A well. At the same time, we will be re-building the A-Lease tank battery. The current tank battery is located at the top of the Mesa near the 1-A well. We will re-build the new battery at the bottom of the Mesa near the new tank battery built for the Lindley 6103 well. 

RESERVIOR ESTIMATES/BUILDING VALUE IN THE GROUND 

The Advanced Reservoir Characterization that was done by NuTech Energy Alliance is not only crucial to the planning of the completion of the existing wells, but also an important factor for determining the reservoir extent of our acreage. As stated in our original Permian Business Plan, we are building value in the ground. Last month we reported the results of the NuTech Advanced Reservoir Characterization. The study indicates that on the Lindley A lease, the Clearfork contains 3,578,310 barrels of recoverable oil per 640 acres. The San Angelo contains 5,158,000 barrels of recoverable oil per 640 acres. The reservoirs calculate to $567,860,150. @ $65. oil for the 2 zones combined. Our 1680-acre Lindley Ranch is estimated to contain 13,565,540 barrels of recoverable oil equivalent or expressed as dollar value, $881,760,100. These represent the Clearfork and San Angelo and have not considered other proven zones. The Canyon Sands have not yet been calculated and will significantly add to the total as our engineer estimates that the wells only achieved a 4% recovery. As a public company, inground reserves can be added to the books as an asset. These reserves will significantly increase the value of the company when added. 

https://twitter.com/stocks0009001/status/1370058694185074692

For more on MDMP Subscribe Right Now!

MDM Permian, LLC (OTC: MDMP) is in full beast mode rocketing up the charts in recent days after the Company reported it has over 20 million barrels of oil in the ground. MDMP is under heavy accumulation and has quickly emerged as the top most traded stock in small caps attracting legions of new shareholders. On Thursday alone MDMP traded over $100 million in dollar volume and rocketed up the charts over 200% as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no fundamentals compared to MDMP.  According to the March 10 release:  “The study indicates that on the Lindley A lease, the Clearfork contains 3,578,310 barrels of recoverable oil per 640 acres. The San Angelo contains 5,158,000 barrels of recoverable oil per 640 acres. The reservoirs calculate to $567,860,150. @ $65. oil for the 2 zones combined. Our 1680-acre Lindley Ranch is estimated to contain 13,565,540 barrels of recoverable oil equivalent or expressed as dollar value, $881,760,100. These represent the Clearfork and San Angelo and have not considered other proven zones. The Canyon Sands have not yet been calculated and will significantly add to the total as our engineer estimates that the wells only achieved a 4% recovery. As a public company, inground reserves can be added to the books as an asset. These reserves will significantly increase the value of the company when added according to MDMP management. We will be updating on MDMP when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MDMP.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in MDMP either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.